In connection with the implementation of the project titled “ Development of a universal fast-response platform, based on RNA technology, ensuring the national drug and epidemiological safety”, funded from the state budget by the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., requested to submit a bid for the purchase and supply of RNA oligonucleotide standards.
Details of the price inquiry can be found in the documents attached below.